Two posters presented at the 2024 American Society of Hematology meeting reported real-world outcomes data for patients ...
Akriti Jain, MD, discusses her presentation from the 2024 American Society of Hematology Meeting and Exposition.
The Barbara Ann Karmanos Cancer Institute welcomes José Larios, M.D., transplant hematologist. Dr. Larios is a member of the ...
Robert M. Rifkin, MD, FACP, discusses how the MagnetisMM-3 update at the 66th American Society of Hematology Annual Meeting and Exposition sheds light on elranatamab’s role in relapsed/refractory ...
Dr. Sattva S. Neelapu discusses the intricacies of CAR T-cell therapy treatment and care for patients with hematologic ...
Mendus AB ("Mendus" publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, announces a summary of the feedback received from the US Food and Drug Administr ...
The Healthy on MSN6d
11 Common Illnesses That Have Been Linked to Alzheimer’sAlthough we don't know a lot about the causes of Alzheimer's disease, the following conditions may raise your risk.
Tribune News Service on MSN1d
Coffee may protect cognition in people with AFibDrinking multiple cups of coffee each day may help prevent cognitive decline in people with a common type of heart rhythm ...
Dr is providing care to patients at the FCS Lake Mary Cancer Center , Deland and Orange City locations. John Bollinger, MD ...
Anglo-Swedish drugmaker AstraZeneca has announced that new, positive, long-term results from the pivotal ALPHA Phase III ...
Researchers developed a novel calculator may help to tailor pain medication regimens to patients with SCD seeking emergency ...
Tafasitamab increased progression free survival by about 9 months when compared to placebo, according to recent study data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback